|
English
|
正體中文
|
简体中文
|
2817115
|
|
???header.visitor??? :
27641008
???header.onlineuser??? :
581
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 660231-660255 of 2307984 (92320 Page(s) Totally)
<< < 26405 26406 26407 26408 26409 26410 26411 26412 26413 26414 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2014-02 |
Pioglitazone and oral cancer risk in patients with type 2 diabetes
|
Tseng, CH |
| 國立成功大學 |
2020 |
Pioglitazone and PPAR-γmodulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: A national cohort study
|
Liu, C.-H.;Lee, T.-H.;Lin, Y.-S.;Sung, P.-S.;Wei, Y.-C.;Li, Y.-R. |
| 臺大學術典藏 |
2022-04-14T23:27:48Z |
Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study
|
CHIN-HSIAO TSENG |
| 國家衛生研究院 |
2022-03-02 |
Pioglitazone and prostate cancer risk in Taiwanese male patients with type 2 diabetes: A retrospective cohort study
|
Tseng, CH |
| 臺大學術典藏 |
2022-06-24T03:00:02Z |
Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study
|
CHIN-HSIAO TSENG |
| 臺大學術典藏 |
2022-03-14T23:45:38Z |
Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
|
CHIN-HSIAO TSENG |
| 臺大學術典藏 |
2022-06-24T02:59:10Z |
Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
|
CHIN-HSIAO TSENG |
| 國家衛生研究院 |
2014-09 |
Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes
|
Tseng, CH |
| 臺大學術典藏 |
2020-06-01T08:33:34Z |
Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes
|
CHIN-HSIAO TSENG; CHIN-HSIAO TSENG |
| 國家衛生研究院 |
2014-08 |
Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes
|
Tseng, CH |
| 國家衛生研究院 |
2013-10 |
Pioglitazone does not affect the risk of ovarian cancer: Analysis of a nationwide reimbursement database in Taiwan
|
Tseng, CH |
| 國立臺灣大學 |
2013 |
Pioglitazone does not affect the risk of ovarian cancer: Analysis of a nationwide reimbursement database in Taiwan
|
Tseng, Chin-Hsiao; 曾慶孝 |
| 國家衛生研究院 |
2019-09-23 |
Pioglitazone exposure reduced the risk of all-cause mortality in insulin-treated patients with type 2 diabetes mellitus
|
Yen, FS;Wang, HC;Pan, CW;Wei, JC;Hsu, CC;Hwu, CM |
| 中山醫學大學 |
2020 |
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus
|
Yen, FS; Wang, HC; Pan, CW; Wei, JCC; Hsu, CC; Hwu, CM |
| 國立成功大學 |
2007 |
Pioglitazone induces adiopocyte differentiation in a murine stromal cell line, DI
|
Hung, S.; Kang, L.; Che, C.; Wang, C.; Chao, D. |
| 國家衛生研究院 |
2018-09-27 |
Pioglitazone reduces dementia risk in patients with type 2 diabetes Mellitus: A retrospective cohort analysis
|
Tseng, CH |
| 國立成功大學 |
2021-08 |
Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice
|
Lam;Ying-Yiu;Tsai;Sheng-Feng;Chen;Pei-Chun;Kuo;Yu-Min;Chen;Yun-Wen |
| 國家衛生研究院 |
2005-11 |
Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients
|
Tseng, CH; Huang, TS |
| 國立臺灣大學 |
2005 |
Pioglitazone with Sulfonylurea: Glycemic and Lipid Effects in Taiwanese Type 2 Diabetic Patients
|
曾慶孝; 黃天祥; TSENG, CHIN-HSIAO; HUANG, TIEN-SHANG |
| 國立臺灣大學 |
2005-07 |
Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients
|
Tseng, CH; HUANG, TS |
| 臺大學術典藏 |
2020-06-01T08:33:59Z |
Pioglitazone with sulfonylurea: Glycemic and lipid effects in Taiwanese type 2 diabetic patients
|
Chin-Hsiao Tseng;Huang T.-S.; CHIN-HSIAO TSENG; Huang T.-S. |
| 臺大學術典藏 |
2020-06-03T08:10:32Z |
Pioglitazone with sulfonylurea: Glycemic and lipid effects in Taiwanese type 2 diabetic patients
|
Tseng C.-H.;Tien-Shang Huang; Tseng C.-H.; TIEN-SHANG HUANG |
| 國立成功大學 |
2018-08-29 |
Pioglitazone, a PPAR-gamma Activator, Stimulates BKCa but Suppresses IKM in Hippocampal Neurons
|
Chen;Tsang-Shan;Lai;Ming-Chi;Hung;Te-Yu;Lin;Kao-Min;Huang;Chin-Wei;Wu;Sheng-Nan |
| 國立成功大學 |
2018 |
Pioglitazone, a PPAR-γ activator, stimulates BKCa but suppresses IKM in hippocampal neurons
|
Chen, T.-S.;Lai, M.-C.;Hung, T.-Y.;Lin, K.-M.;Huang, C.-W.;Wu, S.-N. |
| 高雄醫學大學 |
2007 |
Pioglitazone和類固醇由非經由PPARγ路徑對骨髓幹細胞的酯生成作用
|
陳崇桓;何美泠;張瑞根;洪韶鴻;王國照 |
Showing items 660231-660255 of 2307984 (92320 Page(s) Totally)
<< < 26405 26406 26407 26408 26409 26410 26411 26412 26413 26414 > >>
View [10|25|50] records per page
|
